Skip to Main Content

Paper Details

When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?
Clin Pharmacol Ther
4
2022
participant, patients
Author NameAffiliation
Gregory E SimonKaiser Permanente Washington Health Research Institute
Michael A HorbergKaiser Permanente Mid-Atlantic Permanente Research Institute, Mid-Atlantic Permanente Medical Group
Richard PlattHarvard Medical School, Harvard Pilgrim Health Care Institute
Adrian F HernandezDuke Clinical Research Institute
Robert M CaliffVerily Life Sciences and Google Health
Robert M CaliffVerily Life Sciences and Google Health
  • 1 - 6

Datasets

Release 1.2